Health Care
UROGEN PHARMA LTD URGN
$40.63
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1465 by number of owners
% of all portfolios
0.00%
Rank #1450 by combined value
Net managers Q2 2026
+1
1 in · 0 out
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of Polen Capital's portfolio
Live price
Compare with the quarter-end price of $40.63 reported in the 13F
Superinvestors holding URGN
| Recent activity | |||
|---|---|---|---|
| Polen Capital · Polen Capital Management | 0.0% | ▲ Add+58.0% | $1.9M |